MedTrace Logo

Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation

NCT02647723 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2025-04-22

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to test whether nutritional supplementation during pregnancy is associated with 1) improved maternal health during pregnancy; 2) improved infant birth and neurodevelopmental outcomes, and 3) whether the association between nutritional supplementation during pregnancy and infant outcomes is partially mediated by reductions in maternal perceived stress and stress reactivity during pregnancy.

Conditions

  • Pregnancy
  • Child Development

Interventions

DIETARY_SUPPLEMENT

DHA

2 dietary supplement gel capsules providing 450 mg of DHA twice daily by oral intake for 24 weeks

DIETARY_SUPPLEMENT

Sugar pill

2 dietary supplement gel capsules providing 450 mg of soybean oil twice daily by oral intake for 24 weeks

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • University of Pittsburgh

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Kathryn Keenan, Ph.D · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647723 on ClinicalTrials.gov